News
DeviceSpace Showcases Medical Device and Diagnostics Companies
June 25, 2010 4:35 pm | by Bio-Medicine.Org | CommentsDENVER , June 25 /- DeviceSpace is putting the nation's medical device industry on the map. The leading employment Web site for medical device and diagnostics sectors launched the 2010 U.S. Device™ Hotbed Campaign this morning, marking the campaign's third edition and highlighting...
Harmonized Inspection Standard in CDRH's Future, Official Says
June 25, 2010 4:31 pm | by U.S. Food & Drug Administration | CommentsCDRH is looking forward to a day when it can exchange device information with trusted regulatory authorities in other countries using a harmonized inspection standard.
Increased Collaboration Goal of FDA & #8217;s 10 Foreign Posts
June 25, 2010 4:30 pm | by U.S. Food & Drug Administration | CommentsThe FDA’s foreign posts are working more with regulators and industry to improve the safety of products made overseas.
Power Integrations names CFO
June 25, 2010 12:45 pm | by The Associated Press | CommentsPower Integrations Inc. said Friday that it appointed Sandeep Nayyar as chief financial officer.The appointment is effective immediately.Nayyar replaces Bill Roeschlein, who was fired in May. The company said at the time that the firing wasn't related to financial statements or regulatory...
Down with jet lag
June 25, 2010 7:35 am | by EurekAlert | Comments(Max-Planck-Gesellschaft) The active agent metyrapone influences corticosterone synthesis and enables faster adaptation to altered circadian rhythms.
HeartWare names Larkin as board chairman
June 25, 2010 7:35 am | by Mass High Tech: The Journal of New England Technology | CommentsHeartWare International Inc., a Framingham maker of heart devices, has appointed board member C. Raymond Larkin, Jr. to the role of chairman of the board.
Federal Register: Termination of Declarations Justifying Emergency Use Authorizations of Certain In Vitro Diagnostic Devices, Antiviral Drugs, and Personal Respiratory Protect...
June 25, 2010 7:34 am | by U.S. Food & Drug Administration | CommentsThe FDA is issuing this notice, under the Federal Food, Drug, and Cosmetic Act (the act), of the termination of the declarations of emergency justifying Emergency Use Authorizations (EUAs) of certain in vitro diagnostic devices, personal respiratory...
Federal Register: Guidance for Industry and Food and Drug Administration Staff; In Vitro Diagnostic Studies--Frequently Asked Questions; Availability
June 25, 2010 7:34 am | by U.S. Food & Drug Administration | CommentsFDA is issuing this guidance to assist manufacturers in developing and conducting studies for IVD devices, particularly those exempt from most of the Investigational Device Exemption (IDE) regulations. The guidance explains data considerations that...
Global Manufacturing Competitiveness Index
June 25, 2010 7:34 am | by Material Handling Industry of America | CommentsA report from Deloitte's Global Manufacturing Industry group and the U.S. Council on Competitiveness indicates that access to talented workers capable of supporting innovation is the key factor driving global competitiveness at manufacturing companies-well
Epidemic played large role in shift of attitudes on abortion, author says
June 25, 2010 6:35 am | by EurekAlert | Comments(University of Illinois at Urbana-Champaign) Ten years before the 1973 Supreme Court decision legalizing abortion, German measles probably played the biggest part in starting to shift public attitudes about the criminal abortion laws, University of Illinois historian Leslie J....
A life-changing partnership
June 25, 2010 6:35 am | by EurekAlert | Comments(European Molecular Biology Laboratory) Researchers at EMBL Heidelberg identified a novel regulatory protein complex in Drosophila that explains another protein's double life, and which likely plays an important role in mammals, too.
Eyegate Pharma begins trial for dry eye drug
June 25, 2010 6:35 am | by Mass High Tech: The Journal of New England Technology | CommentsEyegate Pharmaceuticals Inc. has launched a Phase 3 clinical trial for its drug target, called EGP-437, to treat dry eye syndrome. The drug candidate is a type of steroid, delivered using the company's proprietary, non-invasive delivery system, known as Eyegate II.
United Seating & Mobility Launches New Company Website and E-Commerce Store at www.UnitedSeating.com
June 25, 2010 6:34 am | by Bio-Medicine.Org | CommentsALBUQUERQUE, N.M. , June 25 /- United Seating & Mobility, the nation's largest privately-owned mobility and rehab equipment supplier, launched a newly redesigned website today at www.UnitedSeating.com . The new site features in-depth information for clients, families, and clinicians,...
Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting
June 25, 2010 6:34 am | by Bio-Medicine.Org | CommentsCAMBRIDGE, Mass. , June 25 /- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for...
Leading Experts to Speak at Focused Ultrasound Symposium
June 25, 2010 6:33 am | by Bio-Medicine.Org | CommentsFocused Ultrasound Surgery Foundation Announces Speakers, Moderators and Panelists for 2nd International Symposium on MR-Guided Focused Ultrasound CHARLOTTESVILLE, Va. , June 25 /PRNewswire-USNewswire/ -- Leading research and clinical experts from around the world are scheduled to speak...
